- Home
- OPK vs MDXG Comparison
OPK vs MDXG Comparison
Compare OPK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- MDXG
- Stock Information
- Founded
- OPK 2007
- MDXG 2006
- Country
- OPK United States
- MDXG United States
- Employees
- OPK N/A
- MDXG N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- MDXG Health Care
- Exchange
- OPK Nasdaq
- MDXG Nasdaq
- Market Cap
- OPK 1.0B
- MDXG 1.1B
- IPO Year
- OPK 1995
- MDXG N/A
- Fundamental
- Price
- OPK $1.48
- MDXG $8.62
- Analyst Decision
- OPK Strong Buy
- MDXG Strong Buy
- Analyst Count
- OPK 3
- MDXG 5
- Target Price
- OPK $2.75
- MDXG $12.00
- AVG Volume (30 Days)
- OPK 3.4M
- MDXG 716.1K
- Earning Date
- OPK 02-25-2025
- MDXG 02-26-2025
- Dividend Yield
- OPK N/A
- MDXG N/A
- EPS Growth
- OPK N/A
- MDXG N/A
- EPS
- OPK N/A
- MDXG 0.52
- Revenue
- OPK $711,408,000.00
- MDXG $342,804,000.00
- Revenue This Year
- OPK N/A
- MDXG $9.56
- Revenue Next Year
- OPK $0.00
- MDXG $9.19
- P/E Ratio
- OPK N/A
- MDXG $17.19
- Revenue Growth
- OPK N/A
- MDXG 10.93
- 52 Week Low
- OPK $0.86
- MDXG $5.47
- 52 Week High
- OPK $1.76
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- OPK 48.99
- MDXG 39.56
- Support Level
- OPK $1.43
- MDXG $8.50
- Resistance Level
- OPK $1.55
- MDXG $9.71
- Average True Range (ATR)
- OPK 0.05
- MDXG 0.29
- MACD
- OPK 0.00
- MDXG -0.14
- Stochastic Oscillator
- OPK 67.08
- MDXG 6.62
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.